Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Feb 2005

Liu Dongxin, O'Day Steven J, Yang Dongyun, Boasberg Peter, Milford Robert, Kristedja Tim, Groshen Susan, Weber Jeffrey

Abstract excerpt

PURPOSE: Biochemotherapy can achieve high response rates in advanced melanoma, but the factors that influence regression and survival remain unknown. The present exploratory study tested the hypothesis that cytokine gene polymorphisms predict clinical outcome in stage IV melanoma patients treated with biochemotherapy. EXPERIMENTAL DESIGN: Ninety patients with stage IV melanoma were treated with biochemotherapy,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cisplatin
Share to Dacarbazine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endonucleases

Share to Interleukin-2

Share to Pilot Projects

Share to Vinblastine

Share to X-ray Repair Cross Complementing Protein 1

Share to Xeroderma Pigmentosum Group D Protein

Source

Identifiers

PMID: 15709194

Genes

ERCC1
XRCC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study.PMID 15709194Read ↗

Influence of genetic variants in type I interferon genes on melanoma survival and therapy.Semantic proximity Read ↗

Interleukin-1β Gene (IL1B) rs1143634 (+3954 C>T) Polymorphism and Cutaneous Melanoma Risk: An Observational Case-Control Study in Northeast Italy.Semantic proximity Read ↗

Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma.Semantic proximity Read ↗

IL28B polymorphism cannot predict response to interferon alpha treatment in patients with melanoma.Semantic proximity Read ↗

Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population.Semantic proximity Read ↗

Cytokine genotype polymorphisms in breast carcinoma: associations of TGF-beta1 with relapse.Semantic proximity Read ↗

Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690.Semantic proximity Read ↗

Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.Semantic proximity Read ↗

Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients.Semantic proximity Read ↗

A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.Semantic proximity Read ↗

Interleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients.Semantic proximity Read ↗

Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.